Biogen (BIIB) Tops Q4 EPS by 42c; Guides In-Line

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. SPY
10. MRVL

Go back to Biogen (BIIB) Tops Q4 EPS by 42c; Guides In-Line

Biogen 2015 Revenues Increase 11% to $10.8 Billion

January 27, 2016 7:15 AM EST

2015 Non-GAAP Diluted EPS Rise 23%, GAAP Diluted EPS Rise 24%

Company advances leading neuroscience portfolio including programs in Alzheimers disease, spinal muscular atrophy, and a repair & regeneration therapy for multiple sclerosis

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Inc. (NASDAQ: BIIB) today reported full year and fourth quarter 2015 results, including full year revenues of $10.8 billion, an 11% increase versus 2014. Full year 2015 Non-GAAP diluted earnings per share (EPS) were $17.01, an increase of 23% versus 2014. Non-GAAP net income attributable to Biogen Inc. for the year was $3.9 billion, an increase of 20% versus the prior... More